Diamond Competitors

Stocks . Taiwan . 
Stock . Diamond Biotechnology Co
6815 Stock  TWD 60.90  1.20  1.93%   
Diamond Biotechnology competes with Applied BioCode, MedFirst Healthcare, Genovate Biotechnology, Golden Biotechnology, and BenQ Medical; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Diamond Biotechnology competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Diamond Biotechnology to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Diamond Biotechnology Correlation with its peers.

Diamond Biotechnology vs Crystalvue Medical Correlation

Modest diversification

The correlation between Diamond Biotechnology Co and 6527 is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Diamond Biotechnology Co and 6527 in the same portfolio, assuming nothing else is changed.

Moving against Diamond Stock

  0.314174 OBI Pharma SplitPairCorr
Hype
Prediction
LowEstimatedHigh
57.6360.9064.17
Details
Intrinsic
Valuation
LowRealHigh
59.3162.5865.85
Details
Naive
Forecast
LowNextHigh
57.3560.6263.89
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
60.6464.8669.09
Details

Diamond Biotechnology Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Diamond Biotechnology and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Diamond and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Diamond Biotechnology does not affect the price movement of the other competitor.

High positive correlations

6861
+ 0.77
6598
6527
+ 0.72
4116
4130
+ 0.69
6861
4106
+ 0.67
6861
4132
+ 0.64
4175
4106
+ 0.55
6598
  

High negative correlations

6527
- 0.69
4106
6527
- 0.65
4175
4106
- 0.63
4116
6527
- 0.63
4130
6527
- 0.54
4132
6527
- 0.52
6861

Risk-Adjusted Indicators

There is a big difference between Diamond Stock performing well and Diamond Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Diamond Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6598  1.22  0.10  0.03  0.73  1.37 
(1.49)
 2.79 
(2.45)
 8.26 
6861  1.36  0.09  0.02  0.73  1.37 
(1.76)
 2.62 
(2.33)
 13.30 
4175  0.55 (0.03) 0.00 (0.06) 0.00 
 0.00 
 1.04 
(1.19)
 4.50 
4130  2.46  0.79  0.20 (2.04) 2.75 
(2.85)
 9.83 
(5.62)
 20.02 
4132  4.42  0.88  0.15 (2.90) 4.61 
(5.12)
 12.15 
(6.05)
 45.53 
4116  0.69 (0.20) 0.00 (0.62) 0.00 
 0.00 
 1.02 
(1.81)
 4.86 
4153  0.99 (0.20) 0.00 (0.21) 0.00 
 0.00 
 2.14 
(2.29)
 5.86 
9103  1.04  0.09  0.04  0.30  0.96 
(1.43)
 2.23 
(1.67)
 6.57 
4106  0.53  0.15  0.14 (3.37) 0.32 
(0.67)
 1.14 
(0.90)
 2.64 
6527  0.65 (0.11) 0.00 (0.98) 0.00 
 0.00 
 2.01 
(1.10)
 5.09 

Diamond Biotechnology Competitive Analysis

The better you understand Diamond Biotechnology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Diamond Biotechnology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Diamond Biotechnology's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6815 6598 6861 4175 4130 4132 4116 4153 9103 4106
 1.93 
 60.90 
Diamond
 0.84 
 24.15 
Applied
 3.58 
 64.60 
Innocare
 0.17 
 58.30 
MedFirst
 0.16 
 31.70 
Genovate
 2.19 
 18.70 
Golden
 0.57 
 43.85 
BenQ
 0.44 
 33.95 
DIVA
 9.83 
 5.14 
Medtecs
 2.60 
 23.65 
Wellell
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Not too volatile
Somewhat reliable
Very steady
Very steady
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Weakest
Mild
Mild
Weak
Solid
Fair
Weakest
Weakest
Mild
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Unknown
Low
Low
Low
Low
Low
Small
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Sell
Cautious Hold
Strong Sell
Strong Sell
Hold
Hold
Strong Hold
Cautious Hold
Current Ratio
1.49
13.28
N/A
0.94
N/A
2.78
1.53
N/A
1.74
1.73
Net Asset
N/A
1.02 B
N/A
6.79 B
1.52 B
N/A
1.96 B
1.18 B
215.57 M
3.14 B
Profit Margin
14.63
-0.46
N/A
0.0246
0.0069
N/A
0.0653
0.0325
-0.0599
0.0579
EBITDA
104.93 M
(111.35 M)
N/A
687.43 M
39.64 M
(279.28 M)
166.74 M
42.29 M
24.4 M
239.3 M
Operating Margin
17.19
-0.47
N/A
0.0353
0.0083
-414.69
0.0606
0.041
-0.0922
0.0624
Current Valuation
1.03 B
1.72 B
N/A
5.85 B
3.16 B
5.17 B
2.97 B
1.86 B
1.58 B
3.15 B
Price To Book
3.29
2.95
N/A
2.22
2.62
6.75
2.42
2.1
5.23
1.44
Five Year Return
N/A
N/A
N/A
4.58
N/A
N/A
2.49
N/A
N/A
2.56
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
25 M
747 M
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
64 M
1.23 B
Beta
N/A
0.45
N/A
0.27
0.21
0.72
0.79
0.17
1.31
0.32
Number Of Employees
N/A
11
N/A
11
181
135
405
28
15
22
Shares Outstanding
21.39 M
81.76 M
N/A
35.26 M
109.38 M
115.76 M
44.57 M
58.67 M
544.91 M
100.91 M
Cash Flow From Operations
55.99 M
(151.77 M)
N/A
997.95 M
(17.26 M)
(306.43 M)
121.35 M
(11.39 M)
29.76 M
19 M
Annual Yield
N/A
N/A
N/A
0.021
0.0112
N/A
0.0077
0.0096
0.023
0.0178
Total Debt
186.72 M
58.4 M
N/A
1.38 B
N/A
227.3 M
331.25 M
N/A
N/A
122.22 M
Return On Equity
24.77
-0.19
N/A
0.15
0.0022
-36.95
0.16
0.0277
-0.0322
0.0712
Z Score
2.4
23.4
N/A
0.6
N/A
13.2
4.8
N/A
N/A
15.6
Return On Asset
9.36
-0.0936
N/A
0.0245
0.0015
-17.85
0.0386
0.0184
-0.0239
0.032
Book Value Per Share
11.37
10.71
N/A
36.53
12.82
6.59
26.36
16.98
0.32
21.19
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
46 M
936 M
Total Asset
N/A
1.02 B
N/A
6.79 B
1.52 B
N/A
1.96 B
1.18 B
215.57 M
3.14 B
Debt To Equity
0.65
0.054
N/A
183.1
N/A
30.1
18.8
N/A
64.4
36.8
Last Dividend Paid
0.18
N/A
N/A
1.6
0.35
N/A
0.5
0.37
0.006
0.55
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
40.91
Shares Owned By Institutions
N/A
0.04
N/A
0.47
26.96
N/A
0.05
N/A
N/A
18.16
Market Capitalization
801.04 M
2.31 B
N/A
2.67 B
3.3 B
5.15 B
2.83 B
2.23 B
3.9 B
3.2 B
Price To Earning
69.35
N/A
N/A
20.81
N/A
N/A
20.45
N/A
515.0
21.16
Price To Sales
1.84
6.78
N/A
0.4
9.42
65.71
1.14
2.2
45.54
1.21
Net Income
63.59 M
(165.2 M)
N/A
67.93 M
372 K
(336.49 M)
28.84 M
21.86 M
17.34 M
102.25 M
Earnings Per Share
0.54
-2.63
N/A
4.55
0.03
-2.97
3.78
0.46
0.93
1.48
Shares Owned By Insiders
N/A
42.5
N/A
65.12
3.95
N/A
62.62
65.86
N/A
29.68
Revenue
434.54 M
319.96 M
N/A
6.54 B
434.25 M
78.35 M
1.46 B
712.23 M
144.16 M
2.37 B
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
18 M
292 M
Cash And Equivalents
28.51 M
819.75 M
N/A
670.03 M
N/A
152.56 M
284.61 M
N/A
8.21 M
954.69 M
Cash Per Share
1.15
10.03
N/A
22.32
N/A
1.33
6.39
N/A
0.01
9.46
Gross Profit
187.88 M
189.37 M
N/A
1.93 B
149.75 M
51.31 M
512.28 M
181.6 M
43.48 M
986.95 M
Day Typical Price
61.3
24.43
65.63
58.27
31.75
18.83
44.08
34.02
5.14
23.55
Accumulation Distribution
4536.02
10400.7
7640.79
408.7
22417.83
62748.2
397.72
573.81
N/A
11572.65
Market Facilitation Index
1.0E-4
0.0
0.0
1.0E-4
0.0
0.0
0.0
1.0E-4
N/A
0.0
Daily Balance Of Power
(0.24)
0.2105
(0.77)
0.0909
0.0769
0.4
(0.36)
0.1364
9.2 T
0.6667
Period Momentum Indicator
(1.20)
0.2
(2.40)
0.1
0.05
0.4
(0.25)
0.15
0.46
0.6
Rate Of Daily Change
0.98
1.01
0.96
1.0
1.0
1.02
0.99
1.0
1.1
1.03
Day Median Price
61.5
24.58
66.15
58.25
31.78
18.9
44.2
34.05
5.14
23.5
Price Action Indicator
(1.20)
(0.33)
(2.75)
0.1
(0.05)
N/A
(0.47)
(0.03)
0.23
0.45
Relative Strength Index
42.63
57.9
54.55
50.03
59.56
49.74
40.0
41.25
67.92
69.56
Coefficient Of Variation
(4,634)
1330.67
1884.18
(14,328)
480.85
768.21
(568.15)
(941.55)
1374.87
425.2
Mean Deviation
2.26
1.22
1.36
0.5512
2.46
4.42
0.6891
0.9918
1.04
0.5344
Jensen Alpha
(0.20)
0.1012
0.0855
(0.03)
0.7914
0.8753
(0.20)
(0.20)
0.0892
0.1542
Total Risk Alpha
(0.38)
(0.04)
(0.09)
(0.08)
0.4148
0.23
(0.27)
(0.28)
(0.05)
0.0867
Sortino Ratio
N/A
0.0263
0.0169
N/A
0.1962
0.1488
N/A
N/A
0.0419
0.1367
Downside Variance
N/A
2.62
2.24
N/A
12.59
27.87
N/A
N/A
1.26
0.3589
Standard Deviation
3.22
1.62
1.97
0.7346
3.73
6.64
0.9575
1.34
1.74
0.685
Kurtosis
2.13
0.6332
9.13
2.37
1.89
7.05
3.63
1.48
15.4
1.34
Potential Upside
6.22
2.79
2.62
1.04
9.83
12.15
1.02
2.14
2.23
1.14
Treynor Ratio
(0.04)
0.7308
0.731
(0.06)
(2.04)
(2.90)
(0.62)
(0.21)
0.2968
(3.37)
Maximum Drawdown
15.62
8.26
13.3
4.5
20.02
45.53
4.86
5.86
6.57
2.64
Variance
10.35
2.62
3.87
0.5396
13.9
44.14
0.9167
1.8
3.02
0.4693
Market Risk Adjusted Performance
(0.03)
0.7408
0.741
(0.05)
(2.03)
(2.89)
(0.61)
(0.20)
0.3068
(3.36)
Risk Adjusted Performance
(0.01)
0.0608
0.0453
(0.01)
0.1611
0.1047
(0.13)
(0.07)
0.0593
0.1723
Skewness
1.01
0.2032
1.98
0.6228
0.3851
1.73
(1.08)
(0.34)
3.01
0.6925
Semi Deviation
N/A
1.37
1.37
N/A
2.75
4.61
N/A
N/A
0.9644
0.325
Information Ratio
(0.05)
0.0263
0.0128
(0.11)
0.1867
0.1183
(0.26)
(0.17)
0.0271
0.1196
Value At Risk
(4.43)
(2.45)
(2.33)
(1.19)
(5.62)
(6.05)
(1.81)
(2.29)
(1.67)
(0.90)
Expected Short fall
N/A
(1.49)
(1.76)
N/A
(2.85)
(5.12)
N/A
N/A
(1.43)
(0.67)
Downside Deviation
N/A
1.62
1.5
N/A
3.55
5.28
N/A
N/A
1.12
0.5991
Semi Variance
N/A
1.88
1.88
N/A
7.54
21.26
N/A
N/A
0.93
0.1056

Diamond Biotechnology Competition Performance Charts

Five steps to successful analysis of Diamond Biotechnology Competition

Diamond Biotechnology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Diamond Biotechnology in relation to its competition. Diamond Biotechnology's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Diamond Biotechnology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Diamond Biotechnology's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Diamond Biotechnology, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Diamond Biotechnology position

In addition to having Diamond Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Diamond Stock Analysis

When running Diamond Biotechnology's price analysis, check to measure Diamond Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamond Biotechnology is operating at the current time. Most of Diamond Biotechnology's value examination focuses on studying past and present price action to predict the probability of Diamond Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamond Biotechnology's price. Additionally, you may evaluate how the addition of Diamond Biotechnology to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY